Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.
Accounts year has changed to Jan to Dec with April to Dec 22 being a shortened year for accounts as per document filed at Companies House.
Kate Bingham: we have a golden opportunity to give the NHS a hand
to take advantage of its partnerships with the NHS trusts and as per statement with accounts releases the Co plan to concentrate on UK operations.
https://www.thetimes.co.uk/article/ed2b06b4-1103-11ee-a92d-cf7c831c99b5?shareToken=ef03994d56ddd1a56d67dbaef211e09c
Accounts and accompanying statements now available to view at Companies House website.
At long last the Co has lodged the accounts year ending April 22, when they were a listed Co with Companies House and according to the message on that site, they should be available within 10 days. Laura Hillier has also stood down as Company Secretary, that was in a separate notification published last week.
At my average of 1.78 p, I’m certainly hopeful of a good return one day.
Expansion seems rapid
https://uk.linkedin.com/company/arcturis-data
Thanks
…. and what’s great is Arcturis are promoting the article on their LinkedIn feed / latest update.
I guess no one could be bothered to scroll down to the bottom of the article which I post again. It’s a great mention of Arcturis and the first words in public that I’ve seen from Alex Snow.
Article
https://www.thetimes.co.uk/article/d8250bf6-e292-11ed-9d9d-927ca944996b?shareToken=69f9d7d48006a726ae73f772aeccb656
See my latest update on NHS thread. They’ve just updated LinkedIn again with the same info I posted yesterday and confirm partnership with 13 NHS trusts.
They must be monitoring my posts. They’ve just put the same up on their latest LinkedIn update and confirms partnership with 13 NHS trusts
A bit late there see my thread 13th October.
This paper has been out in the public domain fir sometime now
Arcturis have established partnerships already
https://www.arcturisdata.com/resource/evidence-based-trial-protocol-optimisation-themis-trial-showcase/
Rishi Sunak urged to let drug firms use NHS data for new medicines
https://www.thetimes.co.uk/article/d8250bf6-e292-11ed-9d9d-927ca944996b?shareToken=f40467711b1b45ee5e3fa9baa4d8f400
https://www.elsevier.com/connect/why-is-pharma-buzzing-about-real-world-evidence
https://find-and-update.company-information.service.gov.uk/company/09427409/filing-history
Sorry that didn’t copy and psste
Looks good. Certainly some corporate structure there with the job titles and the personnel listed in the who’s who section. I think there is still a lot more to come. Still no accounts published for y/e Apr 22. They appear to be settling the conversion of the loan notes which if I read correctly from the resolutions proposed stands currently at just over £4 M. I stand to be corrected there if I am reading that wrong.
There are eventually only 2 ways to realise value here, either a sale or a re-list, probably in the U.S. Hopefully they will use the website to update on commercial developments when they can. From the info I can see at the moment no date has been set for shareholders to approve the two new resolutions, unless anyone else knows differently.